Advertisement
Screener

Tilray Brands, Inc. (TLRY) Current Federal Tax Expense (Benefit)

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Current Federal Tax Expense (Benefit)

Tilray Brands, Inc. (TLRY) reported Current Federal Tax Expense (Benefit) of $164.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-07-28

  • Tilray Brands, Inc. current federal tax expense (benefit) for fiscal 2026 was $164.00K, a 91.69% decline from fiscal 2025.
  • Tilray Brands, Inc. current federal tax expense (benefit) for fiscal 2025 was $1.97M, a 297.18% increase from fiscal 2024.
  • Tilray Brands, Inc. current federal tax expense (benefit) for fiscal 2024 was $497.00K, a 119.91% increase from fiscal 2023.
  • Tilray Brands, Inc. current federal tax expense (benefit) for fiscal 2023 was $226.00K, a 13.74% decline from fiscal 2022.
Period endCurrent Federal Tax Expense (Benefit) 12 monthCurrent Federal Tax Expense (Benefit) 12 month as first filed
2026-05-31$164.00K
10-K · filed 2026-07-28
2025-05-31$1.97M
10-K · filed 2026-07-28
2024-05-31$497.00K
10-K · filed 2026-07-28
2023-05-31$226.00K
10-K · filed 2025-07-29
2022-05-31$262.00K
10-K · filed 2024-07-30
$23.27M
10-K · filed 2022-07-28
2021-05-31$0.00
10-K · filed 2023-07-26
$15.23M
10-K · filed 2021-07-28
2020-12-31-$88.00K
10-K · filed 2021-02-19
2020-05-31$5.29M
10-K · filed 2022-07-28
2019-12-31$112.00K
10-K · filed 2021-02-19
2019-05-31$3.30M
10-K · filed 2021-07-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87